They conclude, While even more programs, policies and science are still needed to address GBV in MARPs, momentum is definitely building to fill up existing gaps. By capitalizing on PEPFAR’s existing platforms, established interventions for HIV prevention among MARPs, and the range of companions supporting this ongoing work, we can continue steadily to make progress that will bring us closer to the goal of an AIDS-free generation . This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family members Foundation. Kaiser Health Information, an independent news service editorially, is an application of the Kaiser Family Foundation, a nonpartisan health care policy research corporation unaffiliated with Kaiser Permanente..Reveal, how to tailor medical trials to the needs of the patients. Discuss the innovative methods of motivating patients and physicians. Study from first hand encounter, how to optimize patient recruitment & retention, and explore the patient pool in Russia and Southeastern Europe. Achieve the competitive advantage through elevated partnering with educational centres of excellence, patient organizations and CROs. Discuss with leading Pharma companies, what is the continuing future of clinical trials & how to anticipate to succeed. For more info and registration, please visit: About Jacob Fleming Group Jacob Fleming Conferences are carefully designed to provide key strategic business info and the best networking opportunities for the participants.